An antigen-presenting cell vaccine, or an APC vaccine, is a vaccine made of antigens and antigen-presenting cells (APCs).

As of March 2019, the only APC vaccine approved by the American Food and Drug Administration is for prostatic acid phosphatase, a commonly over-expressed prostate cancer antigen.[1][2]

References

  1. ^ O'Neill, David W. (November 2010). "Dendritic cells and T cells in immunotherapy". Journal of Drugs in Dermatology: JDD. 9 (11): 1383–1392. ISSN 1545-9616. PMID 21061761.
  2. ^ MD, Marc S. Ernstoff; FACP, Igor Puzanov, MD, MSCI; PhD, Caroline Robert, MD; MD, Adi M. Diab; PhD, Peter M. Hersey, MD (2019-03-15). SITC's Guide to Managing Immunotherapy Toxicity. Springer Publishing Company. pp. xviii. ISBN 978-0-8261-7215-0.((cite book)): CS1 maint: multiple names: authors list (link)

External links

Public Domain This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.

Categories